Tempest Therapeutics, Inc.
TPST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001544227
No open-market purchases or sales by Tempest Therapeutics, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q3 2026, worth $682.2K in total; no superinvestor holds it.
Holders of 5% or more of TPST
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Tempest Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Angel Matthew | 13D/A | 37.40%5.53M shares | +1.50 ppfrom 35.90% | Feb 10, 20262 filings | Mar 25, 2026 | SEC |
| Sabby Management, LLC | 13G | 9.90%492.2K shares | New | Jan 21, 20261 filing | Jan 21, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
30 Schedule 13D and 13G filings on Tempest Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Apr 2, 20264:30 PM ET | Versant Venture Capital VI, L.P.and 8 others | 13D/A | 1.10%163.0K shares | −2.60 ppfrom 3.70%Below 5% | Mar 30, 2026 | SEC |
| Mar 25, 20265:33 PM ET | Angel Matthew | 13D/A | 37.40%5.53M shares | +1.50 ppfrom 35.90% | Mar 24, 2026 | SEC |
| Feb 10, 20265:15 PM ET | Angel Matthew | 13D | 35.90%4.84M shares | New | Feb 3, 2026 | SEC |
| Jan 21, 20269:27 AM ET | Sabby Management, LLCand 2 others | 13G | 9.90%492.2K shares | New | Dec 31, 2025 | SEC |
| Aug 13, 20257:14 PM ET | Versant Venture Capital VI, L.P.and 8 others | 13D/A | 3.70%163.0K shares | −1.10 ppfrom 4.80%Below 5% | Aug 11, 2025 | SEC |
| Feb 11, 20255:58 PM ET | Versant Venture Capital VI, L.P.and 8 others | 13D/A | 4.80%2.12M shares | –Below 5% | Nov 12, 2024 | SEC |
| Aug 12, 2024 | Versant Venture Capital VI, L.P. | 13D/AOld format | – | – | – | SEC |
| May 13, 2024 | Versant Venture Capital VI, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Rock Springs Capital Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | EcoR1 Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2024 | Versant Venture Capital VI, L.P. | 13D/AOld format | – | – | – | SEC |
| Nov 9, 2023 | Versant Venture Capital VI, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Rock Springs Capital Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | EcoR1 Capital, LLC | 13GOld format | – | New | – | SEC |
| May 9, 2022 | Versant Venture Capital VI, L.P. | 13DOld format | – | – | – | SEC |
| Feb 17, 2022 | LAV Regulus Ltd | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Ikarian Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Roche Finance Ltd | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Citadel Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Versant Venture Capital VI, L.P. | 13GOld format | – | New | – | SEC |
| Jan 3, 2022 | Rock Springs Capital Management LP | 13GOld format | – | – | – | SEC |
| Jul 15, 2021 | Rock Springs Capital Management LP | 13G/AOld format | – | – | – | SEC |
| Jul 8, 2021 | Rock Springs Capital Management LP | 13GOld format | – | New | – | SEC |
| Jul 6, 2021 | FMR LLC | 13GOld format | – | New | – | SEC |
| Apr 13, 2021 | New Enterprise Associates 15, L.P. | 13D/AOld format | – | – | – | SEC |
| Apr 7, 2021 | Ikarian Capital, LLC | 13GOld format | – | New | – | SEC |
| Mar 16, 2021 | Citadel Advisors LLC | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Great Point Partners LLC | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Roche Finance Ltd | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
3 notices from officers, directors and other affiliates planning to sell Tempest Therapeutics, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Aug 13, 20248:03 AM ET | Versant Venture Capital VI, L.P.Owner | 388.0K | $427.0K | Aug 12, 2024 | Jones Trading Institutional Services LLC | SEC |
| Aug 9, 20243:41 PM ET | Versant Venture Capital VI, L.P.10% stockholder | 400.0K | $7.21M | Aug 8, 2024 | BTIG, LLC | SEC |
| Nov 2, 20234:16 PM ET | Dubensky Thomas W.Officer · Director | 30.0K | $131.5K | Oct 25, 2023 | Merrill Lynch | SEC |